Altimmune, Inc. (ALT)
Company Info
| ISIN | US02155H2004 |
|---|---|
| CUSIP | 02155H200 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $489.89M |
|---|---|
| EPS | -$1.66 |
| PE Ratio | 33.50 |
| Revenue (TTM) | $426.00K |
| Gross Profit (TTM) | -$70.52M |
| EBITDA (TTM) | -$83.03M |
| Year Range | $2.09 - $14.84 |
| Target Price | $21.25 |
| Short % | 25.21% |
| Short Ratio | 3.42 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ALT vs. TQQQ, ALT vs. lly, ALT vs. VOO, ALT vs. XLK
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Altimmune, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Altimmune, Inc. had a return of -33.60% year-to-date (YTD) and 29.02% in the last 12 months. Over the past 10 years, Altimmune, Inc. had an annualized return of -33.40%, while the S&P 500 had an annualized return of 10.42%, indicating that Altimmune, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -33.60% | 5.05% |
| 1 month | -17.73% | -4.27% |
| 6 months | 249.07% | 18.82% |
| 1 year | 29.02% | 21.22% |
| 5 years (annualized) | 22.54% | 11.38% |
| 10 years (annualized) | -33.40% | 10.42% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -16.09% | 28.18% | -15.87% | |||||||||
| 2023 | 2.77% | -7.31% | 31.12% | 256.01% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Altimmune, Inc.(ALT)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Altimmune, Inc. (ALT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Altimmune, Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.91 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.87% |
Monthly Dividends
The table displays the monthly dividend distributions for Altimmune, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | |||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $2.91 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Altimmune, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Altimmune, Inc. was 99.94%, occurring on Nov 19, 2019. The portfolio has not yet recovered.
The current Altimmune, Inc. drawdown is 99.72%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.94% | Mar 15, 2006 | 3409 | Nov 19, 2019 | — | — | — |
| -4.98% | Feb 28, 2006 | 5 | Mar 6, 2006 | 3 | Mar 9, 2006 | 8 |
| -2.7% | Oct 31, 2005 | 6 | Nov 7, 2005 | 32 | Dec 23, 2005 | 38 |
| -2.25% | Feb 7, 2006 | 7 | Feb 15, 2006 | 5 | Feb 23, 2006 | 12 |
| -2.25% | Jan 3, 2006 | 4 | Jan 6, 2006 | 16 | Jan 31, 2006 | 20 |
Volatility
Volatility Chart
The current Altimmune, Inc. volatility is 24.33%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |